Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner

BioTechniques

Volumn 35, Issue 1, 2003, Pages 164-168

  Haedicke, Wolfgang ^a   Popper, Helmut H ^b   Buck, Charles R ^a   Zatloukal, Kurt ^a,b  

^a ORIDIS Biomed GmbH   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENS; DNA; FLUORESCENCE; IMMUNOLOGY; PROTEINS; SCANNING;

LASER SCANNERS;

TISSUE;

ANTIGEN; COMPLEMENTARY DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN;

ARTICLE; AUTOANALYSIS; COMPUTER PROGRAM; DNA MICROARRAY; DNA MICROARRAY SCANNER; EQUIPMENT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LABORATORY AUTOMATION; LASER SCANNER; LUNG ADENOCARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE HISTOCHEMISTRY; SQUAMOUS CELL CARCINOMA; TECHNIQUE; TISSUE MICROARRAY; TISSUE SLICE;

EID: 0038678771     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/03351md04     Document Type: Article

References (15)

1. Kononen, J., L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, et al. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:844-847.
2. Tschulik, A. and K. Zatloukal. 2001. The increasing importance of tumor and tissue banks in the light of genomic and proteomic research. Pathologe 22:310-315.
3. Hoos, A., M.J. Urist, A. Stojadinovic, S. Mastorides, M.E. Dudas, D.H. Leung, D. Kuo, M.F. Brennan, et al. 2001. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathol. 158:1245-1251.
4. Mucci, N.R., G. Akdas, S. Manely, and M.A. Rubin. 2000. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum. Pathol. 31:406-414.
5. Schaafsma, H.E. and F.C. Ramaekers. 1994. Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathol. Annu. 29Pt1:21-62.
6. Fickert, P., M. Trauner, A. Fuchsbichler, C. Stumptner, K. Zatloukal, and H. Denk. 2002. Cytokeratins as targets for bile acid-induced toxicity. Am. J. Pathol. 160:491-499.
7. Pfeiffer, P., P.P. Clausen, K. Andersen, and C. Rose. 1996. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br. J. Cancer 74:86-91.
8. Tateishi, M., T. Ishida, T. Mitsudomi, S. Kaneko, and K. Sugimachi. 1991. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur. J. Cancer 27:1372-1375.
9. Sobin, L.H. (Ed.). 2002. TNM Classification of Malignant Tumours. John Wiley & Sons, New York.
10. Carbognani, P., L. Spaggiari, A. Romani, P. Solli, A. Corradi, A.M. Cantoni, P.G. Petronini, A.F. Borghetti, et al. 1998. Expression of human CD44v6 in non-small-cell lung cancer. Eur. Surg. Res. 30:403-408.
11. Hirata, T., T. Fukuse, H. Naiki, S. Hitomi, and H. Wada. 1998. Expression of CD44 variant exon 6 in stage 1 non-small cell lung carcinoma as a prognostic factor. Cancer Res. 58:1108-1110.
12. Ramasami, S., K.M. Kerr, A.D. Chapman, G. King, J.S. Cockburn, and R.R. Jeffrey. 2000. Expression of CD44v6 but not E-cadherin or β-catenin influences prognosis in primary pulmonary adenocarcinoma. J. Pathol. 192:427-432.
13. Volm, M., G. van Kaick, and J. Mattern. 1994. Analysis of c-fos, e-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clin. Exp. Metastasis 12:329-334.
14. Kristiansen, G., Y. Yu, S. Petersen, O. Kaufmann, K. Schluns, M. Dietel, and I. Petersen. 2001. Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 focus in non-small cell lung cancer. Eur. J. Cancer 37:1089-1095.
15. Franklin, W.A., R. Veve, F.R. Hirsch, B.A. Helfrich, and P.A. Bunn, Jr. 2002. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin. Oncol 29:3-14.